Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice

被引：0
|
作者：
Tong Li
Jiandong Wang
机构：
[1] Beijing Obstetrics and Gynecology Hospital,Department of Gynecologic Oncology
[2] Capital Medical University,undefined
来源：
BMC Cancer | / 20卷
关键词：
Chimeric antigen receptor T cell; Mucin 16; Programmed cell death-ligand 1; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Development of a novel L1CAM-targeted CAR-T, CX804, and its therapeutic efficacy in ovarian and gastric cancer
    Che, Xiumei
    Yun, Un-Jung
    Lee, Seokwon
    Kim, Youngyoub
    Lee, Junshub
    Chae, Jina
    Suh, Jehee
    Nam, Eun-Ji
    Kim, Gun Min
    Kim, Hyoyoung
    Jung, Minkyu
    CANCER RESEARCH, 2023, 83 (07)
  • [32] Tandem CAR-T cells targeting MUC1 and PSCA combined with anti-PD-1 antibody exhibit potent preclinical activity against non-small cell lung cancer
    Wang, Aying
    Lv, Tangfeng
    Song, Yong
    CELLULAR IMMUNOLOGY, 2023, 391
  • [33] Anti-MUC1 CAR-T cells combined with PD-1 knockout engineered T cells for patients with non-small cell lung cancer (NSCLC): A pilot study
    Chen, S.
    Lin, Y.
    Zhong, S.
    An, H.
    Lu, Y.
    Yin, M.
    Liang, W.
    McGowan, E. M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [34] Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells (vol 10, e004479corr1, 2022)
    Martin-Otal, C.
    Lasarte-Cia, A.
    Serrano, D.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (09)
  • [35] Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma
    Posey, Avery D., Jr.
    Schwab, Robert D.
    Boesteanu, Alina C.
    Steentoft, Catharina
    Mandel, Ulla
    Engels, Boris
    Stone, Jennifer D.
    Madsen, Thomas D.
    Schreiber, Karin
    Haines, Kathleen M.
    Cogdill, Alexandria P.
    Chen, Taylor J.
    Song, Decheng
    Scholler, John
    Kranz, David M.
    Feldman, Michael D.
    Young, Regina
    Keith, Brian
    Schreiber, Hans
    Clausen, Henrik
    Johnson, Laura A.
    June, Carl H.
    IMMUNITY, 2016, 44 (06) : 1444 - 1454
  • [36] Chimeric Antigen receptor-T (CAR-T) cells targeting Epithelial cell adhesion molecule (EpCAM) can inhibit tumor growth in ovarian cancer mouse model
    Fu, Juan
    Shang, Yuhong
    Qian, Zhang
    Hou, Jinping
    Yan, Feng
    Liu, Guodi
    Li Dehua
    Tian, Xiaoli
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2021, 83 (02): : 241 - 247
  • [37] CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer
    Duan, Zhijian
    Li, Dan
    Li, Nan
    Lin, Shaoli
    Ren, Hua
    Hong, Jessica
    Hinrichs, Christian S.
    Ho, Mitchell
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (04):
  • [38] Targeting axonal guidance with anti-ROBO1 CAR T cells: A new therapeutic strategy for malignant brain cancer
    Singh, Sheila Kumari
    Chokshi, Chirayu R.
    Brakel, Benjamin
    Rossotti, Martin A.
    Venugopal, Chitra
    Salim, Sabra
    Henry, Kevin
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers
    Ba, Hongping
    Dai, Zigang
    Zhang, Zunyue
    Zhang, Peng
    Yin, Bingjiao
    Wang, Jing
    Li, Zhuoya
    Zhou, Xiaoxi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (01)
  • [40] Chemokine receptor CCR2b expressing anti-Tn-MUC1 CAR-T cells enhanced anti-breast cancer activity
    Lin, Y.
    Yin, H.
    An, H.
    Zhou, C.
    Zhou, L.
    Chen, S.
    McGowan, E.
    ANNALS OF ONCOLOGY, 2019, 30
12345